{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T04:53:42Z","timestamp":1791608022540,"version":"4.3.4"},"update-to":[{"DOI":"10.12688\/wellcomeopenres.17636.1","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000}}],"reference-count":40,"publisher":"F1000 Research Ltd","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","award":["5U01GH002133-02"],"award-info":[{"award-number":["5U01GH002133-02"]}],"id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","award":["52863073_CRG"],"award-info":[{"award-number":["52863073_CRG"]}],"id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Wellcome","award":["093804, 102975, 077092"],"award-info":[{"award-number":["093804, 102975, 077092"]}]}],"content-domain":{"domain":["wellcomeopenresearch.org"],"crossmark-restriction":false},"short-container-title":["Wellcome Open Res"],"abstract":"<ns3:p>\n                    <ns3:bold>Background:<\/ns3:bold>\n                    Maternal immunisation to boost respiratory syncytial virus (RSV) antibodies in pregnant women, is a strategy being considered to enhance infant protection from severe RSV associated disease. However, little is known about the efficiency of transplacental transfer of RSV-specific antibodies in a setting with a high burden of malaria and HIV, to guide the implementation of such a vaccination program.\n                  <\/ns3:p>\n                  <ns3:p>\n                    <ns3:bold>Methods:<\/ns3:bold>\n                    Using a plaque reduction neutralization assay, we screened 400 pairs of cord and maternal serum specimens from pregnant women for RSV-specific antibodies. Participants were pregnant women of two surveillance cohorts: 200 participants from a hospital cohort in Kilifi, Coastal Kenya and 200 participants from a surveillance cohort in Siaya, Western Kenya. Transplacental transfer efficiency was determined by the cord to maternal titre ratio (CMTR). Logistic regression was used to determine independent predictors of impaired transplacental transfer of RSV-specific antibodies.\n                  <\/ns3:p>\n                  <ns3:p>\n                    <ns3:bold>Results:<\/ns3:bold>\n                    A total of 800 samples were screened from the 400 participants. At enrollment the median age was 25 years (Interquartile range (IQR): 21-31). Overall, transplacental transfer was efficient and did not differ between Kilifi and Siaya cohort (1.02 vs. 1.02; p=0.946) but was significantly reduced among HIV-infected mothers compared to HIV-uninfected mothers (mean CMTR: 0.98 vs 1.03; p=0.015). Prematurity &lt;33 weeks gestation (Odds ratio [OR]: 0.23, 95% confidence interval [CI] 0.06\u20130.85; p=0.028), low birth weight &lt;2.5 kgs (OR: 0.25, 95% CI: 0.07\u20130.94; p=0.041) and HIV infection (OR: 0.47, 95% CI:0.23-0.98; p=0.045) reduced efficiency of transplacental transfer among these women.\n                  <\/ns3:p>\n                  <ns3:p>\n                    <ns3:bold>Conclusions:<\/ns3:bold>\n                    Transplacental transfer of RSV-specific antibodies among pregnant women in Kenya is efficient. A consideration to integrate other preventive interventions with maternal RSV vaccination targeting infants born premature (&lt;33 weeks gestation), with low birth weight &lt;2.5 kgs, or HIV-infected mothers is likely to improve vaccine outcomes in this setting.\n                  <\/ns3:p>","DOI":"10.12688\/wellcomeopenres.17636.2","type":"journal-article","created":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T09:52:03Z","timestamp":1648806723000},"page":"43","update-policy":"https:\/\/doi.org\/10.12688\/wellcomeopenres.crossmark-policy","source":"Crossref","is-referenced-by-count":12,"title":["Efficiency of transplacental transfer of respiratory syncytial virus (RSV) specific antibodies among pregnant women in Kenya"],"prefix":"10.12688","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7215-6539","authenticated-orcid":false,"given":"Joyce U.","family":"Nyiro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Bukusi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dufton","family":"Mwaengo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7865-8756","authenticated-orcid":false,"given":"Amek","family":"Nyaguara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryan","family":"Nyawanda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy","family":"Otieno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Godfrey","family":"Bigogo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5304-2210","authenticated-orcid":false,"given":"Nickson","family":"Murunga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0682-6933","authenticated-orcid":false,"given":"Marc-Alain","family":"Widdowson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer R.","family":"Verani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9453-7057","authenticated-orcid":false,"given":"Sandra S.","family":"Chaves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1166-8965","authenticated-orcid":false,"given":"Hope","family":"Mwangudza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Calleb","family":"Odundo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1236-849X","authenticated-orcid":false,"given":"James A.","family":"Berkley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5426-1984","authenticated-orcid":false,"given":"D James","family":"Nokes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9419-7155","authenticated-orcid":false,"given":"Patrick K.","family":"Munywoki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2560","published-online":{"date-parts":[[2022,4,1]]},"reference":[{"key":"ref-1","doi-asserted-by":"publisher","first-page":"1545-1555","DOI":"10.1016\/S0140-6736(10)60206-1","article-title":"Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis.","volume":"375","author":"H Nair","year":"2010","journal-title":"Lancet."},{"key":"ref-2","doi-asserted-by":"publisher","first-page":"757-779","DOI":"10.1016\/S0140-6736(19)30721-4","article-title":"Causes of severe pneumonia requiring hospital admission in children without HIV infection from Africa and Asia: the PERCH multi-country case-control study.","volume":"394","year":"2019","journal-title":"Lancet."},{"key":"ref-3","doi-asserted-by":"publisher","first-page":"1341-1349","DOI":"10.1086\/606055","article-title":"Incidence and severity of respiratory syncytial virus pneumonia in rural Kenyan children identified through hospital surveillance.","volume":"49","author":"D Nokes","year":"2009","journal-title":"Clin Infect Dis."},{"key":"ref-4","doi-asserted-by":"publisher","first-page":"946-958","DOI":"10.1016\/S0140-6736(17)30938-8","article-title":"Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: a systematic review and modelling study.","volume":"390","author":"T Shi","year":"2017","journal-title":"Lancet."},{"key":"ref-5","doi-asserted-by":"publisher","first-page":"1456-1463","DOI":"10.1016\/s0264-410x(98)00108-x","article-title":"Maternal immunization against viral disease.","volume":"16","author":"J Englund","year":"1998","journal-title":"Vaccine."},{"key":"ref-6","doi-asserted-by":"publisher","first-page":"426-439","DOI":"10.1056\/NEJMoa1908380","article-title":"Respiratory Syncytial Virus Vaccination during Pregnancy and Effects in Infants.","volume":"383","author":"S Madhi","year":"2020","journal-title":"N Engl J Med."},{"key":"ref-7","doi-asserted-by":"publisher","first-page":"708-715","DOI":"10.1016\/s0022-3476(81)80829-3","article-title":"Risk of respiratory syncytial virus infection for infants from low-income families in relationship to age, sex, ethnic group, and maternal antibody level.","volume":"98","author":"W Glezen","year":"1981","journal-title":"J Pediatr."},{"key":"ref-8","doi-asserted-by":"publisher","first-page":"616-623","DOI":"10.1002\/jmv.10148","article-title":"Prevalence of respiratory syncytial virus IgG antibodies in infants living in a rural area of Mozambique.","volume":"67","author":"A Roca","year":"2002","journal-title":"J Med Virol."},{"key":"ref-9","doi-asserted-by":"publisher","first-page":"4726-4729","DOI":"10.1016\/j.vaccine.2014.05.038","article-title":"The association between age and the development of respiratory syncytial virus neutralising antibody responses following natural infection in infants.","volume":"32","author":"C Sande","year":"2014","journal-title":"Vaccine."},{"key":"ref-10","doi-asserted-by":"publisher","first-page":"1700-1706","DOI":"10.1080\/21645515.2016.1145847","article-title":"Antibody response to respiratory syncytial virus infection in children < 18 months old.","volume":"12","author":"S Esposito","year":"2016","journal-title":"Hum Vaccin Immunother."},{"key":"ref-11","doi-asserted-by":"publisher","first-page":"124-135","DOI":"10.1016\/j.ebiom.2017.01.014","article-title":"Age-Specific Profiles of Antibody Responses against Respiratory Syncytial Virus Infection.","volume":"16","author":"N Jounai","year":"2017","journal-title":"EBioMedicine."},{"key":"ref-12","doi-asserted-by":"publisher","first-page":"2870-2875","DOI":"10.1016\/j.vaccine.2016.03.109","article-title":"Advances in RSV vaccine research and development - A global agenda.","volume":"34","author":"D Higgins","year":"2016","journal-title":"Vaccine."},{"key":"ref-13","article-title":"RSV vaccine and mAb snapshot","year":"2020"},{"key":"ref-14","doi-asserted-by":"publisher","first-page":"477-479","DOI":"10.1128\/cdli.3.4.477-479.1996","article-title":"Prevalence of neutralizing antibody to respiratory syncytial virus in sera from mothers and newborns residing in the Gambia and in The United States.","volume":"3","author":"R Suara","year":"1996","journal-title":"Clin Diagn Lab Immunol."},{"key":"ref-15","doi-asserted-by":"publisher","first-page":"234-239","DOI":"10.1002\/(sici)1096-9071(199807)55:3<234::aid-jmv9>3.0.co;2-2","article-title":"Seroepidemiological study of respiratory syncytial virus in Sao Paulo state, Brazil.","volume":"55","author":"M Cox","year":"1998","journal-title":"J Med Virol."},{"key":"ref-16","doi-asserted-by":"publisher","first-page":"782-786","DOI":"10.1002\/jmv.27383","article-title":"Transplacental transfer of RSV antibody in Australian First Nations infants.","volume":"94","author":"N Homaira","year":"2022","journal-title":"J Med Virol."},{"key":"ref-17","doi-asserted-by":"publisher","first-page":"985646","DOI":"10.1155\/2012\/985646","article-title":"IgG placental transfer in healthy and pathological pregnancies.","volume":"2012","author":"P Palmeira","year":"2012","journal-title":"Clin Dev Immunol."},{"key":"ref-18","doi-asserted-by":"publisher","first-page":"90-95","DOI":"10.1016\/j.jcv.2017.08.017","article-title":"Transplacental transfer of maternal respiratory syncytial virus (RSV) antibody and protection against RSV disease in infants in rural Nepal.","volume":"95","author":"H Chu","year":"2017","journal-title":"J Clin Virol."},{"key":"ref-19","doi-asserted-by":"publisher","first-page":"15-26","DOI":"10.1016\/0143-4004(91)90506-b","article-title":"Localization of three subtypes of Fc gamma receptors in human placenta by immunohistochemical analysis.","volume":"12","author":"T Kameda","year":"1991","journal-title":"Placenta."},{"key":"ref-20","doi-asserted-by":"publisher","first-page":"529-534","DOI":"10.1046\/j.1365-3156.2001.00741.x","article-title":"The influence of prematurity and low birthweight on transplacental antibody transfer in a rural West African population.","volume":"6","author":"J Okoko","year":"2001","journal-title":"Trop Med Int Health."},{"key":"ref-21","doi-asserted-by":"publisher","first-page":"627-632","DOI":"10.1086\/322808","article-title":"The influence of placental malaria infection and maternal hypergammaglobulinemia on transplacental transfer of antibodies and IgG subclasses in a rural West African population.","volume":"184","author":"B Okoko","year":"2001","journal-title":"J Infect Dis."},{"key":"ref-22","doi-asserted-by":"publisher","first-page":"635-641","DOI":"10.1097\/00006454-200007000-00010","article-title":"Placental transfer and decay of maternally acquired antimeasles antibodies in Nigerian children.","volume":"19","author":"H Hartter","year":"2000","journal-title":"Pediatr Infect Dis J."},{"key":"ref-23","doi-asserted-by":"publisher","first-page":"47-51","DOI":"10.1590\/s1413-86702008000100011","article-title":"Placental transfer of Haemophilus influenzae type b antibodies in malnourished pregnant women.","volume":"12","author":"R Cavalcante","year":"2008","journal-title":"Braz J Infect Dis."},{"key":"ref-24","doi-asserted-by":"publisher","first-page":"6466-6468","DOI":"10.1016\/j.vaccine.2015.07.086","article-title":"Embedding surveillance into clinical care to detect serious adverse events in pregnancy.","volume":"33","author":"A Seale","year":"2015","journal-title":"Vaccine."},{"key":"ref-25","doi-asserted-by":"publisher","first-page":"jiaa490","DOI":"10.1093\/infdis\/jiaa490","article-title":"The impact of maternal HIV infection on the burden of respiratory syncytial virus among pregnant women and their infants, western Kenya.","author":"B Nyawanda","year":"2020","journal-title":"J Infect Dis."},{"key":"ref-26","doi-asserted-by":"publisher","first-page":"2020-2025","DOI":"10.1002\/jmv.23696","article-title":"Kinetics of the neutralizing antibody response to respiratory syncytial virus infections in a birth cohort.","volume":"85","author":"C Sande","year":"2013","journal-title":"J Med Virol."},{"key":"ref-27","doi-asserted-by":"publisher","first-page":"33","DOI":"10.12688\/wellcomeopenres.15108.1","article-title":"Agreement between ELISA and plaque reduction neutralisation assay in Detection of respiratory syncytial virus specific antibodies in a birth Cohort from Kilifi, coastal Kenya [version 1; peer review: 2 approved, 2 approved with reservations].","volume":"4","author":"J Nyiro","year":"2019","journal-title":"Wellcome Open Res."},{"key":"ref-28","doi-asserted-by":"publisher","first-page":"489-492","DOI":"10.1093\/infdis\/jis700","article-title":"Group- and genotype-specific neutralizing antibody responses against respiratory syncytial virus in infants and young children with severe pneumonia.","volume":"207","author":"C Sande","year":"2013","journal-title":"J Infect Dis."},{"key":"ref-29","doi-asserted-by":"publisher","first-page":"7641-7649","DOI":"10.1016\/j.vaccine.2018.10.087","article-title":"Establishment of the first WHO International Standard for antiserum to Respiratory Syncytial Virus: Report of an international collaborative study.","volume":"36","author":"J McDonald","year":"2018","journal-title":"Vaccine."},{"key":"ref-30","article-title":"Replication Data for: Efficiency of transplacental transfer of respiratory syncytial virus (RSV) specific antibodies among pregnant women in Kenya.","author":"J Nyiro","year":"2021"},{"key":"ref-31","doi-asserted-by":"publisher","first-page":"614246","DOI":"10.3389\/fimmu.2021.614246","article-title":"Reduced Placental Transfer of Antibodies Against a Wide Range of Microbial and Vaccine Antigens in HIV-Infected Women in Mozambique.","volume":"12","author":"S Alonso","year":"2021","journal-title":"Front Immunol."},{"key":"ref-32","doi-asserted-by":"publisher","first-page":"169-177","DOI":"10.1080\/00034989958654","article-title":"The influence of prematurity and low birthweight on transplacental antibody transfer in Sri Lanka.","volume":"93","author":"H Wesumperuma","year":"1999","journal-title":"Ann Trop Med Parasitol."},{"key":"ref-33","doi-asserted-by":"publisher","first-page":"521-534","DOI":"10.1016\/j.ogc.2014.08.001","article-title":"Maternal immunization to benefit the mother, fetus, and infant.","volume":"41","author":"G Swamy","year":"2014","journal-title":"Obstet Gynecol Clin North Am."},{"key":"ref-34","doi-asserted-by":"publisher","first-page":"234-243","DOI":"10.1053\/tm.2000.7393","article-title":"Placental Fc receptors and the transfer of maternal IgG.","volume":"14","author":"E Kristoffersen","year":"2000","journal-title":"Transfus Med Rev."},{"key":"ref-35","doi-asserted-by":"publisher","first-page":"349-356","DOI":"10.1093\/jpids\/piz056","article-title":"Placental Transfer of Respiratory Syncytial Virus Antibody Among HIV-Exposed, Uninfected Infants.","volume":"9","author":"S Patel","year":"2020","journal-title":"J Pediatric Infect Dis Soc."},{"key":"ref-36","doi-asserted-by":"publisher","first-page":"F202-205","DOI":"10.1136\/fn.79.3.f202","article-title":"Placental antibody transfer: influence of maternal HIV infection and placental malaria.","volume":"79","author":"M de Moraes-Pinto","year":"1998","journal-title":"Arch Dis Child Fetal Neonatal Ed."},{"key":"ref-37","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.3389\/fimmu.2017.01294","article-title":"Factors Affecting the FcRn-Mediated Transplacental Transfer of Antibodies and Implications for Vaccination in Pregnancy.","volume":"8","author":"C Wilcox","year":"2017","journal-title":"Front Immunol."},{"key":"ref-38","doi-asserted-by":"publisher","first-page":"338","DOI":"10.3389\/fimmu.2016.00338","article-title":"Transfer of Maternal Antimicrobial Immunity to HIV-Exposed Uninfected Newborns.","volume":"7","author":"B Abu-Raya","year":"2016","journal-title":"Front Immunol."},{"key":"ref-39","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.3389\/fimmu.2020.01920","article-title":"Update on Transplacental Transfer of IgG Subclasses: Impact of Maternal and Fetal Factors.","volume":"11","author":"T Clements","year":"2020","journal-title":"Front Immunol."},{"key":"ref-40","doi-asserted-by":"publisher","first-page":"e199-e202","DOI":"10.1097\/INF.0000000000002364","article-title":"Hypergammaglobulinemia and Impaired Transplacental Transfer of Respiratory Syncytial Virus Antibody in Papua New Guinea.","volume":"38","author":"J Atwell","year":"2019","journal-title":"Pediatr Infect Dis J."}],"container-title":["Wellcome Open Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/wellcomeopenresearch.org\/articles\/7-43\/v2\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/wellcomeopenresearch.org\/articles\/7-43\/v2\/pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/wellcomeopenresearch.org\/articles\/7-43\/v2\/iparadigms","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T11:05:46Z","timestamp":1648811146000},"score":1,"resource":{"primary":{"URL":"https:\/\/wellcomeopenresearch.org\/articles\/7-43\/v2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,1]]},"references-count":40,"URL":"https:\/\/doi.org\/10.12688\/wellcomeopenres.17636.2","relation":{"has-review":[{"id-type":"doi","id":"10.21956\/wellcomeopenres.19709.r49637","asserted-by":"subject"},{"id-type":"doi","id":"10.21956\/wellcomeopenres.19709.r49637","asserted-by":"object"}]},"ISSN":["2398-502X"],"issn-type":[{"value":"2398-502X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,1]]},"assertion":[{"value":"Indexed","URL":"https:\/\/wellcomeopenresearch.org\/articles\/7-43\/v2#article-reports","order":0,"name":"referee-status","label":"Referee status","group":{"name":"current-referee-status","label":"Current Referee Status"}},{"value":"10.21956\/wellcomeopenres.19508.r48576, Kondwani Charles Jambo, Malawi-Liverpool-Wellcome Trust Clinical Research Programme, University of Malawi College of Medicine, Blantyre, Malawi, 15 Feb 2022, version 1, 1 approved, 1 not approved","URL":"https:\/\/wellcomeopenresearch.org\/articles\/7-43\/v1#referee-response-48576","order":0,"name":"referee-response-48576","label":"Referee Report","group":{"name":"article-reports","label":"Article Reports"}},{"value":"<b>Joyce Nyiro<\/b>; \n<i>Posted: 24 Mar 2022<\/i>; \n<i>Thank you for your comments and positive feedback on our manuscript. The referred paragraph 3 in the manuscript\u2019s discussion section has now been deleted.<\/i>","URL":"https:\/\/wellcomeopenresearch.org\/articles\/7-43\/v2#referee-comment-4952","order":1,"name":"referee-comment-4952","label":"Referee Comment","group":{"name":"article-reports","label":"Article Reports"}},{"value":"10.21956\/wellcomeopenres.19709.r49637, Beate Kampmann, The Vaccine Centre, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, UK, 01 Apr 2022, version 2, indexed","URL":"https:\/\/wellcomeopenresearch.org\/articles\/7-43\/v2#referee-response-49637","order":2,"name":"referee-response-49637","label":"Referee Report","group":{"name":"article-reports","label":"Article Reports"}},{"value":"This work was supported by Pfizer (Grant # 52863073_CRG), CDC (Grant# 5U01GH002133-02) and Wellcome (Grant # 093804, 102975 and 077092). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","order":3,"name":"grant-information","label":"Grant Information"},{"value":"This is an open access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.","order":0,"name":"copyright-info","label":"Copyright"}]}}